Previous 10 | Next 10 |
SAN CARLOS, Calif. , Nov. 27, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced results of a study published in the Journal of Prenatal Diagnosis which demonstrated that measuring individual fetal frac...
Healthcare Pulse Healthcare is at its all-time highs eclipsing the highs recorded a year earlier during the Oct-Nov 2018 period. Of course, if one looks at the broader market which has been recording such all-time highs since the summer of this year, it's understandable to shrug shoulders ...
This article takes a look at the best-performing small-cap stocks with a list that presents an interesting group of emerging companies that are fast-growing or have attracted significant bullish sentiment based on a strong outlook. We take the Russell 2000 ( IWM ) constituents as our univers...
The following slide deck was published by Natera, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Natera, Inc. (NTRA) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Michael Brophy – Chief Financial Officer Steve Chapman – Chief Executive Officer Solomon Moshkevich – General Manager-Oncology and Transplant Bob Schueren ...
Natera (NASDAQ: NTRA ): Q3 GAAP EPS of -$0.33 beats by $0.22 . Revenue of $77.9M (+19.3% Y/Y) beats by $3.93M . Press Release More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news,
SAN CARLOS, Calif. , Nov. 6, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the third quarter ended September 30, 2019 and provided an update on recent...
AAOI , AEL , AIMT , ALB , ANGI , ANSS , ASRT , ATO , ATSG , AXGN , BAND , BIDU , BL , BNFT , BRKS , CECO , CNDT , COLL , CTL , CVNA , CXW , DAR , DCP , DVAX , DXCM , DXPE , EBS , ECPG , EGAN , ENS , EOG , EQH , ERI , ET , EVRG , EXPE , FG , FISV , FIT ...
SAN CARLOS, Calif. , Oct. 30, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its third quarter ended September 30, 2019 , after the market close on November 6, 2019 . Natera will host a ...
Natera (NASDAQ: NTRA ) prices its public offering of 5.714M common shares at $35/share. More news on: Natera, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...